• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体前叶多巴胺受体。D-2多巴胺受体高亲和力和低亲和力状态的相互转换证明。

Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor.

作者信息

Sibley D R, De Lean A, Creese I

出版信息

J Biol Chem. 1982 Jun 10;257(11):6351-61.

PMID:6176582
Abstract

The interactions of dopaminergic agonists and antagonists with binding sites in bovine anterior pituitary membranes have been investigated with radioligand-binding techniques and computer-modeling procedures. 3H-labeled agonist binding is stereospecific, reversible, saturable, and of high affinity. The rank order of catecholamines, phenothiazines, and related drugs in competing for 3H-agonist binding is indicative of interactions with a D-2 dopamine receptor. Both agonist/3H-agonist and antagonist/3H-agonist competition curves are monophasic and noncooperative (nH = 1) with computer analysis indicating a single class of binding sites. Specific 3H-agonist binding can be completely inhibited by guanine nucleotides. GppNHp us the most potent nucleotide followed by GTP and GDP which are equipotent. The equilibrium binding capacity for 3H-labeled antagonists is twice that for 3H-agonists. Unlabeled antagonists inhibit 3H-antagonist binding competitively and exhibit antagonist/3H-antagonist competition curves which model best to a state of homogeneous affinity. In contrast, unlabeled agonists inhibit 3H-antagonist binding in a heterogeneous fashion displaying multiphasic (nH less than 1) competition curves which can be resolved into high and low affinity binding sites. In the presence of saturating concentrations of guanine nucleotides, however, the agonist/3H-antagonist curves model best to a single affinity state which is identical with the low affinity state seen in control curves. The binding data can be explained by postulating two states of the D-2 dopamine receptor, inducible by agonists but not antagonists and modulated by guanine nucleotides.

摘要

已运用放射性配体结合技术和计算机建模程序,研究了多巴胺能激动剂和拮抗剂与牛垂体前叶膜中结合位点的相互作用。3H标记的激动剂结合具有立体特异性、可逆性、饱和性且亲和力高。儿茶酚胺、吩噻嗪及相关药物在竞争3H激动剂结合时的排序,表明它们与D-2多巴胺受体存在相互作用。激动剂/3H激动剂和拮抗剂/3H激动剂竞争曲线均为单相且非协同性的(nH = 1),计算机分析表明存在单一类别的结合位点。特异性3H激动剂结合可被鸟嘌呤核苷酸完全抑制。GppNHp是最有效的核苷酸,其次是等效的GTP和GDP。3H标记拮抗剂的平衡结合能力是3H激动剂的两倍。未标记的拮抗剂竞争性抑制3H拮抗剂结合,并呈现出最符合均匀亲和力状态的拮抗剂/3H拮抗剂竞争曲线。相比之下,未标记的激动剂以异质性方式抑制3H拮抗剂结合,呈现多相(nH小于1)竞争曲线,可解析为高亲和力和低亲和力结合位点。然而,在鸟嘌呤核苷酸饱和浓度存在的情况下,激动剂/3H拮抗剂曲线最符合单一亲和力状态,该状态与对照曲线中所见的低亲和力状态相同。结合数据可通过假设D-2多巴胺受体的两种状态来解释,这两种状态可由激动剂而非拮抗剂诱导,并受鸟嘌呤核苷酸调节。

相似文献

1
Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor.垂体前叶多巴胺受体。D-2多巴胺受体高亲和力和低亲和力状态的相互转换证明。
J Biol Chem. 1982 Jun 10;257(11):6351-61.
2
Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.垂体前叶中的多巴胺D2受体:单一群体,不存在相互拮抗/激动状态。
J Neurochem. 1985 Apr;44(4):1168-77. doi: 10.1111/j.1471-4159.1985.tb08740.x.
3
Agonist binding promotes a guanine nucleotide reversible increase in the apparent size of the bovine anterior pituitary dopamine receptors.激动剂结合会促进牛垂体前叶多巴胺受体表观大小的鸟嘌呤核苷酸可逆性增加。
J Biol Chem. 1983 Nov 25;258(22):13528-34.
4
Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland.长期雌激素治疗可促进大鼠垂体前叶中D2多巴胺受体的功能解偶联。
Endocrinology. 1989 Jan;124(1):346-55. doi: 10.1210/endo-124-1-346.
5
Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.麦角生物碱与垂体前叶D-2多巴胺受体的相互作用。
Mol Pharmacol. 1983 May;23(3):585-93.
6
Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide.小牛脑中D2 - 多巴胺受体的激动剂高亲和力和低亲和力状态。鸟嘌呤核苷酸的部分转化作用。
Mol Pharmacol. 1984 Jan;25(1):10-7.
7
Characterization of high-affinity dopamine D2 receptors and modulation of affinity states by guanine nucleotides in cholate-solubilized bovine striatal preparations.
J Neurochem. 1986 Nov;47(5):1493-502. doi: 10.1111/j.1471-4159.1986.tb00784.x.
8
Guanine nucleotide effects on agonist binding at D2 dopamine receptors in bovine anterior pituitary.鸟嘌呤核苷酸对牛垂体前叶D2多巴胺受体激动剂结合的影响。
Biochem Pharmacol. 1986 Mar 1;35(5):731-5. doi: 10.1016/0006-2952(86)90239-x.
9
Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.
Mol Pharmacol. 1985 Feb;27(2):171-83.
10
Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.激动剂与D-2多巴胺受体的相互作用:大鼠纹状体膜中存在处于多种激动剂亲和状态的单一受体群体的证据。
Biochem Pharmacol. 1984 Mar 15;33(6):877-87. doi: 10.1016/0006-2952(84)90441-6.

引用本文的文献

1
The Non-Anhydrous, Minimally Basic Synthesis of the Dopamine D Agonist [18F]MCL-524.多巴胺 D 激动剂[18F]MCL-524 的非无水、微碱性合成
Chemistry (Basel). 2021 Sep;3(3):1047-1056. doi: 10.3390/chemistry3030075. Epub 2021 Sep 9.
2
Dopamine D3 Receptor in Parkinson Disease: A Prognosis Biomarker and an Intervention Target.帕金森病中的多巴胺 D3 受体:一个预后生物标志物和干预靶点。
Curr Top Behav Neurosci. 2023;60:89-107. doi: 10.1007/7854_2022_373.
3
Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia.
多巴胺 D1 受体刺激作为精神分裂症的一种潜在认知目标机制。
Schizophr Bull. 2022 Jan 21;48(1):199-210. doi: 10.1093/schbul/sbab095.
4
The High Affinity Dopamine D Receptor Agonist MCL-536: A New Tool for Studying Dopaminergic Contribution to Neurological Disorders.高亲和力多巴胺D受体激动剂MCL-536:研究多巴胺能对神经疾病影响的新工具。
ACS Chem Neurosci. 2021 Apr 21;12(8):1428-1437. doi: 10.1021/acschemneuro.1c00094. Epub 2021 Apr 12.
5
A Split Luciferase Complementation Assay for the Quantification of β-Arrestin2 Recruitment to Dopamine D-Like Receptors.一种用于定量检测β-arrestin2 募集到多巴胺 D 样受体的分裂萤光素酶互补分析方法。
Int J Mol Sci. 2020 Aug 24;21(17):6103. doi: 10.3390/ijms21176103.
6
Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D Dopamine Receptor Agonist.发现、优化和表征 ML417:一种新型高选择性 D 多巴胺受体激动剂。
J Med Chem. 2020 May 28;63(10):5526-5567. doi: 10.1021/acs.jmedchem.0c00424. Epub 2020 May 12.
7
Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?G蛋白偶联受体激动剂放射性示踪剂在PET神经成像中能发挥作用吗?
Front Mol Neurosci. 2019 Oct 18;12:255. doi: 10.3389/fnmol.2019.00255. eCollection 2019.
8
Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging.用激动剂示踪剂寻找高亲和力状态的 G 蛋白偶联受体:正电子发射断层成像的理论和实际考虑因素。
Med Res Rev. 2019 May;39(3):1014-1052. doi: 10.1002/med.21552. Epub 2018 Nov 18.
9
New Dopamine D2 Receptor Agonist, [H]MCL-536, for Detecting Dopamine D2high Receptors in Vivo.新型多巴胺 D2 受体激动剂 [H]MCL-536,用于体内探测多巴胺 D2 高亲和力受体。
ACS Chem Neurosci. 2018 Jun 20;9(6):1283-1289. doi: 10.1021/acschemneuro.8b00096. Epub 2018 Apr 16.
10
Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia.抗精神病药物治疗的精神分裂症患者纹状体多巴胺 D2 受体的亲和状态。
Int J Neuropsychopharmacol. 2017 Nov 1;20(11):928-935. doi: 10.1093/ijnp/pyx063.